The Contractor shall provide analytical services for the analysis of bulk pharmaceutical substances and formulated drug products. Reports of analytical testing on bulk drugs and dosage forms will be used as a basis for assessing the suitability of these materials for use in screening, pharmacological studies, toxicological studies, formulation studies, or for clinical trials. These data will be supplied to the Food and Drug Administration (FDA) as part of the Investigational New Drug (IND) filings for new antitumor and anti-AIDS agents. Historical summaries of the data will be used in procurement actions as well as for the routine quality control of these materials. In addition, solubility and stability data will be developed, and selected assay methods will be adapted for the quantitation of drug in plasma. These data will be provided to other contract projects to facilitate formulation development, and to aid in the analytical aspects of pharmacology and, toxicological testing.

Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CM077014-008
Application #
6339535
Study Section
Project Start
1997-06-01
Project End
2002-05-31
Budget Start
2000-08-04
Budget End
2001-05-31
Support Year
Fiscal Year
2000
Total Cost
$400,580
Indirect Cost
Name
Midwest Research Institute
Department
Type
DUNS #
007173453
City
Kansas City
State
MO
Country
United States
Zip Code
64110